Immunohistochemistry
Immunohistochemistry
批准号:
7796928
负责人:
Ellen Pure'
金额:
$26.44万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2014-06-30
关键词:
AcuteAddressAdultAnimalsAntigensAortic AneurysmApoptosisApoptoticArchitectureAreaArterial Fatty StreakAtherosclerosisBlood PlateletsBlood VesselsCardiovascular DiseasesCardiovascular systemCause of DeathCell CycleCell ProliferationCellsColorComplementComputer softwareCyberneticsDetectionDevelopmentDisease OutcomeE600EicosanoidsEndothelial CellsEnsureEnvironmental Risk FactorEquipmentEventExtracellular MatrixFamily suidaeFibrosisFoam CellsFunctional disorderGene ExpressionGenerationsGeneticGenomicsGoalsHarvestHistologicHuman ResourcesImageImage AnalysisImmunohistochemistryIndividualInflammationInflammatoryInflammatory InfiltrateInjuryKnowledgeLesionLightingMicroscopeModelingMolecularMusMyocardial InfarctionOutcomePathway interactionsPatientsPhenotypeProceduresPropertyProteinsProteomicsProtocols documentationPublicationsRegulationResearchResolutionRiskRuptureScheduleServicesSignal TransductionSilverSmooth Muscle MyocytesStagingStaining methodStainsStrokeTechnologyTimeTissue EmbeddingTissuesTrainingTranslatingUnited StatesVascular Endothelial CellVascular remodelingcell typecryostatdesignfemoral arterygenetic manipulationhemodynamicshypercholesterolemiainsightpreventprogramsresponseresponse markerrestenosistherapy developmenttissue processing
中文摘要
核心B:免疫组织化学(IHC)核心将提供组成和结构的表征
英文摘要
Core B: The Immunohistochemstry (IHC) Core will provide characterization of the composition and architecture
of vascular lesions (atherosclerosis, aortic aneurysms and femoral artery wire-induced injury)
(Projects 1 & 4), and ofthe temporal and spatial regulation of vascular gene expression by hemodynamic
forces and hypercholesterolemia (Project 5) using standardized protocols. Services include (i) training
personnel in individual projects to harvest and embed tissue appropriately for IHC analysis, (ii) cutting and
mounting of cryostat sections in a manner that allows quantitative analysis of morphologic regions over
defined areas of lesion, (iii) histochemical and immunohistochemical staining and counterstaining of serial
sections, (iv) image analysis of processed tissue and training in quantitative image analysis of personnel in
individual projects, (v) generation of and training in the generation of publication quality composites of
images. In addition to already standardized protocols for the detection of for example, various infiltrating
inflammatory cell types, foam cells, endothelial cells, vascular smooth muscle cells (at various stages of
differentiation), cycling cells, apoptotic cells and extracellular matrix components, the core will develop
optimized protocols for detection of additional antigens (such as PAF for platelet involvement), markers of
oxidative responses and markers of the unfolded protein response as needed to support each project. The
Core Director will participate up front in designing animal studies that will require IHC analysis to ensure that
tissues from optimal numbers of animals per group and at optimal time points will be available for analysis,
and in determining the appropriate panel of targets to be analysed to address specific hypotheses regarding
mechanisms underlying lesion the development, composition and architecture of lesions. The Core Director
will assist individuals from the various projects in interpreting IHC results. Core activities will utilize existing
equipment including a Microm HM505 E cryostat, Leica Leitz DMRD upright microscope with bright field
illumination, Nikon E 600 upright microscope with bright field illumination. Image Pro Plus image analysis software (Media Cybernetics, Silver Spring, MD), HP color laserjet 2550 LN and Canon Image Press Cl printers. Procedures for coordinated scheduling and for assuring equitable access to core services are in place. The histochemical and immunohistochemical analysis provided by the Core will provide additional approaches for quantification of the extent of lesion and will provide important insights into the mechanisms
that modulate the extent of lesions as well as the properties of lesions that can impact outcome, i.e. more fibrotic versus inflammatory atherosclerotic lesions that may translate into vulnerability to plaque rupture.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of the stromal cell surface protease FAP in pancreatic cancer
-
批准号:8511917
-
项目类别:
-
资助金额:$11.92万
-
财政年份:2013
-
负责人:Ellen Pure'
-
依托单位:
The role of the stromal cell surface protease FAP in pancreatic cancer
-
批准号:8636413
-
项目类别:
-
资助金额:$15.9万
-
财政年份:2013
-
负责人:Ellen Pure'
-
依托单位:
The role of the stromal cell surface protease FAP in pancreatic cancer
-
批准号:8786229
-
项目类别:
-
资助金额:$10.53万
-
财政年份:2013
-
负责人:Ellen Pure'
-
依托单位:
Fibroblast Activation Protein in the Tumor Microenvironment in Lung Cancer
-
批准号:7889926
-
项目类别:
-
资助金额:$33.96万
-
财政年份:2010
-
负责人:Ellen Pure'
-
依托单位:
Fibroblast Activation Protein in the Tumor Microenvironment in Lung Cancer
-
批准号:8214619
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2010
-
负责人:Ellen Pure'
-
依托单位:
Fibroblast Activation Protein in the Tumor Microenvironment in Lung Cancer
-
批准号:8728438
-
项目类别:
-
资助金额:$29.78万
-
财政年份:2010
-
负责人:Ellen Pure'
-
依托单位:
Fibroblast Activation Protein in the Tumor Microenvironment in Lung Cancer
-
批准号:8045525
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2010
-
负责人:Ellen Pure'
-
依托单位:
Fibroblast Activation Protein in the Tumor Microenvironment in Lung Cancer
-
批准号:8444543
-
项目类别:
-
资助金额:$28.37万
-
财政年份:2010
-
负责人:Ellen Pure'
-
依托单位:
Regulation of smooth muscle cell function by CD44 in cardiovascular disease
-
批准号:8247826
-
项目类别:
-
资助金额:$40.58万
-
财政年份:2009
-
负责人:Ellen Pure'
-
依托单位:
Regulation of smooth muscle cell function by CD44 in cardiovascular disease
-
批准号:8051524
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2009
-
负责人:Ellen Pure'
-
依托单位:
Regulation of smooth muscle cell function by CD44 in cardiovascular disease
-
批准号:7799958
-
项目类别:
-
资助金额:$41.02万
-
财政年份:2009
-
负责人:Ellen Pure'
-
依托单位:
Regulation of smooth muscle cell function by CD44 in cardiovascular disease
-
批准号:7653544
-
项目类别:
-
资助金额:$42.71万
-
财政年份:2009
-
负责人:Ellen Pure'
-
依托单位:
Oxidative Modifications of CD44 and Hyaluronan
-
批准号:7001732
-
项目类别:
-
资助金额:$18.08万
-
财政年份:2003
-
负责人:Ellen Pure'
-
依托单位:
CD44 mediated airway hyperresponsiveness and inflammation induced by allergen
-
批准号:6663418
-
项目类别:
-
资助金额:$32.1万
-
财政年份:2002
-
负责人:Ellen Pure'
-
依托单位:
ENDOGENOUS MECHANISMS THAT LIMIT INFLAMMATION
-
批准号:6497285
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2001
-
负责人:Ellen Pure'
-
依托单位:
Proinflammatory Effects of CD44 on Atherosclerosis
-
批准号:6331795
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2001
-
负责人:Ellen Pure'
-
依托单位:
ENDOGENOUS MECHANISMS THAT LIMIT INFLAMMATION
-
批准号:6843744
-
项目类别:
-
资助金额:$32.08万
-
财政年份:2001
-
负责人:Ellen Pure'
-
依托单位:
Proinflammatory Effects of CD44 on Atherosclerosis
-
批准号:6638688
-
项目类别:
-
资助金额:$36.03万
-
财政年份:2001
-
负责人:Ellen Pure'
-
依托单位:
ENDOGENOUS MECHANISMS THAT LIMIT INFLAMMATION
-
批准号:6266310
-
项目类别:
-
资助金额:$30.73万
-
财政年份:2001
-
负责人:Ellen Pure'
-
依托单位:
Proinflammatory Effects of CD44 on Atherosclerosis
-
批准号:6726921
-
项目类别:
-
资助金额:$36.36万
-
财政年份:2001
-
负责人:Ellen Pure'
-
依托单位:
海外基金